Reata Pharmaceuticals
Biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
$6.6b
Enterprise valuation
$6.4b (Public information from Sep 2023)
Share price
$172.36 RETA
Plano Texas (HQ)
Authorizing premium user...